Yoseph Bornstein Sells 35,000 Shares of Microbot Medical Inc (NASDAQ:MBOT) Stock

Microbot Medical Inc (NASDAQ:MBOT) Director Yoseph Bornstein sold 35,000 shares of Microbot Medical stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $1.06, for a total transaction of $37,100.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Yoseph Bornstein also recently made the following trade(s):

  • On Tuesday, January 2nd, Yoseph Bornstein sold 42,132 shares of Microbot Medical stock. The stock was sold at an average price of $1.01, for a total transaction of $42,553.32.
  • On Wednesday, December 27th, Yoseph Bornstein sold 14,257 shares of Microbot Medical stock. The stock was sold at an average price of $1.02, for a total transaction of $14,542.14.
  • On Tuesday, December 19th, Yoseph Bornstein sold 32,067 shares of Microbot Medical stock. The stock was sold at an average price of $1.03, for a total transaction of $33,029.01.
  • On Tuesday, December 12th, Yoseph Bornstein sold 44,159 shares of Microbot Medical stock. The stock was sold at an average price of $1.04, for a total transaction of $45,925.36.
  • On Wednesday, December 6th, Yoseph Bornstein sold 15,375 shares of Microbot Medical stock. The stock was sold at an average price of $1.05, for a total transaction of $16,143.75.
  • On Tuesday, November 21st, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.21, for a total transaction of $54,450.00.
  • On Tuesday, November 28th, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.07, for a total transaction of $48,150.00.
  • On Tuesday, October 24th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.14, for a total transaction of $57,000.00.
  • On Tuesday, October 17th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.16, for a total transaction of $58,000.00.

Microbot Medical Inc (NASDAQ MBOT) traded up $0.03 during trading hours on Friday, hitting $1.07. 863,594 shares of the company were exchanged, compared to its average volume of 794,680. Microbot Medical Inc has a 52 week low of $1.00 and a 52 week high of $9.94. The company has a market cap of $42.50, a PE ratio of -1.55 and a beta of -0.41.

A hedge fund recently raised its stake in Microbot Medical stock. Vanguard Group Inc. boosted its holdings in Microbot Medical Inc (NASDAQ:MBOT) by 252.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 159,992 shares of the biotechnology company’s stock after buying an additional 114,561 shares during the period. Vanguard Group Inc. owned approximately 0.43% of Microbot Medical worth $228,000 as of its most recent filing with the Securities and Exchange Commission. 4.66% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/20/insider-selling-microbot-medical-inc-mbot-director-sells-37100-00-in-stock.html.

About Microbot Medical

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply